Question

Difficulty: Very hardPulmonary and Critical Care

A 45-year-old woman is evaluated in the outpatient clinic for a 6-month history of progressive shortness of breath on exertion and profound fatigue. She recently experienced an episode of lightheadedness that nearly resulted in syncope while climbing stairs. She has no significant past medical history, takes no medications, and has never smoked. Vital signs show a heart rate of 92/min92/\text{min}, blood pressure of 118/74 mmHg118/74\text{ mmHg}, and oxygen saturation of 97%97\% on room air. Physical examination reveals a palpable right ventricular heave and a prominently accentuated P2P_2 component of the second heart sound. The lungs are clear to auscultation bilaterally. An electrocardiogram demonstrates right axis deviation and right ventricular hypertrophy. Chest radiography shows prominent central pulmonary arteries with rapid tapering of the peripheral vessels and clear lung fields.

Arrange the following diagnostic and management steps in the most appropriate chronological order according to guideline-directed evaluation of suspected pulmonary hypertension.

  1. 1Perform transthoracic echocardiography
  2. 2Obtain a radionuclide ventilation-perfusion (V/Q) scan
  3. 3Perform right heart catheterization
  4. 4Conduct an acute pulmonary vasodilator challenge

Answer

The correct sequential order for evaluating suspected pulmonary hypertension is: 1) Transthoracic echocardiography, 2) Radionuclide ventilation-perfusion (V/Q) scan, 3) Right heart catheterization, and 4) Acute pulmonary vasodilator challenge.
The diagnostic approach to unexplained pulmonary hypertension (PH) follows a strict algorithmic sequence. First, transthoracic echocardiography is performed to estimate pulmonary pressures and rule out left-sided heart disease (Group 2 PH). Second, a ventilation-perfusion (V/Q) scan is obtained to screen for chronic thromboembolic pulmonary hypertension (CTEPH, Group 4), as it is more sensitive than CT angiography for chronic disease. Third, if noninvasive workup points to Group 1 Pulmonary Arterial Hypertension (PAH), right heart catheterization is mandatory to definitively measure hemodynamics (mean pulmonary artery pressure ≥20 mmHg\geq 20\text{ mmHg}, pulmonary capillary wedge pressure ≤15 mmHg\leq 15\text{ mmHg}, and pulmonary vascular resistance ≥3\geq 3 Wood units). Finally, during the right heart catheterization, an acute vasodilator challenge is conducted using a short-acting agent (e.g., inhaled nitric oxide) to identify patients who are candidates for calcium channel blocker therapy.

Step-by-Step Solution

1
Initial noninvasive screening with TTE.
Estimates pulmonary artery pressures and evaluates for left-sided heart disease.
TTE is the safest, most accessible initial test to confirm clinical suspicion of PH and rule out Group 2 PH (left heart disease).
2
Noninvasive etiologic evaluation with a V/Q scan.
Screens for chronic thromboembolic pulmonary hypertension (CTEPH).
A V/Q scan is the imaging modality of choice (more sensitive than CT pulmonary angiography) for ruling out Group 4 PH before proceeding to invasive testing.
3
Invasive hemodynamic confirmation via RHC.
Accurately measures mean pulmonary artery pressure (mPAP), pulmonary capillary wedge pressure (PCWP), and pulmonary vascular resistance (PVR).
RHC is the gold standard required to definitively diagnose pulmonary arterial hypertension (PAH) and differentiate pre-capillary from post-capillary etiologies.
4
Therapeutic triaging with an acute vasodilator challenge.
Determines pulmonary vasoreactivity.
Performed during the RHC in patients with confirmed Group 1 PAH to identify the minority of patients who will safely respond to long-term high-dose calcium channel blocker therapy.

Key Concept

The diagnostic algorithm for pulmonary hypertension requires sequential noninvasive screening (echocardiography), etiologic workup (V/Q scan for CTEPH), invasive confirmation (right heart catheterization), and therapeutic triaging (vasodilator testing).
Estimated Time:1m 30s
Rate this question